EDQM WORKSHOP ON ALTERNATIVES TO LEPTOSPIROSIS BATCH POTENCY TEST 26-27 January 2012 EDQM, Strasbourg, France ABSTRACTS
نویسندگان
چکیده
ABSTRACT 1 ........................................................................................................................................ 3 Review of 1999 International Conference on Alternatives to Animal Challenge Tests in the Batch Control of Leptospira Vaccines for Veterinary Use Lukas Bruckner, Institute of Virology and Immunoprophylaxis (IVI), Mittelhäusern, Switzerland1 ........................................................................................................................................ 3 Review of 1999 International Conference on Alternatives to Animal Challenge Tests in the Batch Control of Leptospira Vaccines for Veterinary Use Lukas Bruckner, Institute of Virology and Immunoprophylaxis (IVI), Mittelhäusern, Switzerland ABSTRACT 2 ........................................................................................................................................ 4 Leptospirosis: need for multi-serovar vaccines The occurrence in animals in Belgium and Europe. Els Goossens, Isabelle Behaeghel, CODA-CERVA, Veterinary and Agrochemical Research Centre, Brussels, Belgium2 ........................................................................................................................................ 4 Leptospirosis: need for multi-serovar vaccines The occurrence in animals in Belgium and Europe. Els Goossens, Isabelle Behaeghel, CODA-CERVA, Veterinary and Agrochemical Research Centre, Brussels, Belgium ABSTRACT 3 ........................................................................................................................................ 5 Analysis of multiple Leptospira vaccine proteomes and identification of LipL32 as a potential biomarker for potency P.C. Humphryes, M.E. Weeks, A. Gielbert, G. Thomson, N.G. Coldham, Animal Health and Veterinary Laboratories Agency3 ........................................................................................................................................ 5 Analysis of multiple Leptospira vaccine proteomes and identification of LipL32 as a potential biomarker for potency P.C. Humphryes, M.E. Weeks, A. Gielbert, G. Thomson, N.G. Coldham, Animal Health and Veterinary Laboratories Agency ABSTRACT 4 ........................................................................................................................................ 6 Protein profiling of inactivated Leptospira vaccines an alternative to animal testing? Elisabeth Balks, Constanze Wolf, Heike Gyra4 ........................................................................................................................................ 6 Protein profiling of inactivated Leptospira vaccines an alternative to animal testing? Elisabeth Balks, Constanze Wolf, Heike Gyra ABSTRACT 5 ........................................................................................................................................ 7 Leptospira Hardjo vaccine potency testing based on ELISA alternative, OIE Leptospirosis Reference Laboratory, Veterinary Sciences Division, AFBI, Belfast, Northern Ireland Zbigniew Arent, William Ellis5 ........................................................................................................................................ 7 Leptospira Hardjo vaccine potency testing based on ELISA alternative, OIE Leptospirosis Reference Laboratory, Veterinary Sciences Division, AFBI, Belfast, Northern Ireland Zbigniew Arent, William Ellis ABSTRACT 6 ........................................................................................................................................ 8 Leptospira Dr Eric Klaasen, Intervet6 ........................................................................................................................................ 8 Leptospira Dr Eric Klaasen, Intervet ABSTRACT 7 ...................................................................................................................................... 10 Leptospira In vitro potency test High level review of MERIAL activities on Leptospira potency testing J. Reyes and J. Lechenet7 ...................................................................................................................................... 10 Leptospira In vitro potency test High level review of MERIAL activities on Leptospira potency testing J. Reyes and J. Lechenet
منابع مشابه
AGAATI/ECVAM Workshop on the Validation of Alternative Methods for the Potency Testing of Vaccines.
The workshop on validation of alternative methods for the potency testing of vaccines was organised by ECVAM (European Centre for the Validation of Alternative Methods) and AGAATI (Advisory Group on Alternatives to Animal Testing in Immunobiologicals), and it was held in Angera, Italy, on 14-16 November 1997 under the co-chairmanship of Coenraad Hendriksen (RIVM, Bilthoven, The Netherlands) and...
متن کاملTheme I Safety and Efficacy Testing of Chemicals, Pharmaceuticals and Biologicals Session I-1: Potency and safety testing of human vaccines Session I-1: Oral presentations
the eDQM (european Directorate for the Quality of Medicines & Health Care, Council of europe) is a standard setting body involved in ensuring the quality of medicines, including vaccines for human and veterinary use. this is done through the elaboration and publication of the european Pharmacopoeia (Ph. eur.). In addition, the eDQM runs the Biological Standardisation Programme (BSP) which elabo...
متن کاملCollaborative study for the establishment of the second international standard for gramicidin.
An international collaborative study was organised by the European Directorate for the Quality of Medicines & HealthCare (EDQM) to establish the WHO second International Standard (IS) for gramicidin as the stocks of the 1st IS, established in 1964, were close to depletion. The candidate material did not show any sign of potency loss when kept at elevated temperatures of + 4 °C, + 20 °C, + 37 °C...
متن کاملCollaborative study for the establishment of the second international standard for vancomycin.
An international collaborative study has been organised by the European Directorate for the Quality of Medicines & HealthCare (EDQM) to establish the World Health Organization (WHO) 2nd International Standard (IS) for Vancomycin. Twelve laboratories from 10 different countries participated. The potency of the candidate material, a freeze-dried preparation, was estimated by microbiological assay...
متن کاملEDQM’s 3R Activities in the Field of Quality Control of Vaccines
The European Directorate for the Quality of Medicines and HealthCare is committed to promoting the principles of the 3Rs. In the field of quality control of medicines, EDQM activities concerned with the application of these principles include: the elaboration of the European Pharmacopoeia, the Official Medicines Control Laboratory network – in particular, the network for Official Control Author...
متن کامل